| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.02 |